Reduced biliary sterol output with no change in total faecal excretion in mice expressing a human apolipoprotein A-I variant

Liver International

Volumn 32, Issue 9, 2012, Pages 1363-1371

  Parolini, Cinzia ^a   Caligari, Silvia ^a   Gilio, Donatella ^a   Manzini, Stefano ^a   Busnelli, Marco ^a   Montagnani, Marco ^b   Locatelli, Marcello ^b   Diani, Erika ^a   Giavarini, Flavio ^a   Caruso, Donatella ^a   Roda, Enrico ^b   Roda, Aldo ^b   Sirtori, Cesare R ^a   Chiesa, Giulia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Apolipoprotein A I; Apolipoprotein A IMilano; Bile acids; Cholesterol; Gene knock in; HDL; Liver; Transgenic mice

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; BILE ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SCAVENGER RECEPTOR BI; STEROL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE ACID METABOLISM; BILE COMPOSITION; BILE FLOW; BLOOD SAMPLING; CHOLESTEROL LIVER LEVEL; FECES; LIPID DIET; LIPID STORAGE; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STEROL METABOLISM;

ANIMALS; APOLIPOPROTEIN A-I; ATP-BINDING CASSETTE TRANSPORTERS; BILE; CHOLESTEROL, HDL; DISEASE MODELS, ANIMAL; FECES; GASTROINTESTINAL CONTENTS; GENE EXPRESSION PROFILING; HUMANS; LIVER; MALE; MICE; MODELS, ANIMAL; SCAVENGER RECEPTORS, CLASS B;

EID: 84865743356     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2012.02855.x     Document Type: Article

References (39)

1. Luc G, Bard JM, Ferrieres J, et al. Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Arterioscler Thromb Vasc Biol 2002; 22: 1155-61.
2. Weissglas-Volkov D, Pajukanta P. Genetic causes of high and low serum HDL-cholesterol. J Lipid Res 2010; 51: 2032-57.
3. Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 2005; 96: 1221-32.
4. Botham KM, Bravo E. The role of lipoprotein cholesterol in biliary steroid secretion. Studies with in vivo experimental models. Prog Lipid Res 1995; 34: 71-97.
5. Spady DK, Woollett LA, Meidell RS, Hobbs HH. Kinetic characteristics and regulation of HDL cholesteryl ester and apolipoprotein transport in the apoA-I-/- mouse. J Lipid Res 1998; 39: 1483-92.
6. Jolley CD, Dietschy JM, Turley SD. Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein A-I. Hepatology 2000; 32: 1309-16.
7. Secknus R, Darby GH, Chernosky A, et al. Apolipoprotein A-I in bile inhibits cholesterol crystallization and modifies transcellular lipid transfer through cultured human gall-bladder epithelial cells. J Gastroenterol Hepatol 1999; 14: 446-56.
8. Amigo L, Quinones V, Leiva A, et al. Apolipoprotein A-I deficiency does not affect biliary lipid secretion and gallstone formation in mice. Liver Int 2011; 31: 263-71.
9. Franceschini G, Sirtori CR, Capurso A 2nd, Weisgraber KH, Mahley RW. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J Clin Invest 1980; 66: 892-900.
10. Weisgraber KH, Rall SC, Bersot TP Jr, et al. Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I. J Biol Chem 1983; 258: 2508-13.
11. Milano apoprotein with plasma lipid and lipoprotein patterns. Atherosclerosis 1985; 58: 159-74.
12. Milano mutant: the Limone sul Garda study. Circulation 2001; 103: 1949-54.
13. Gomaraschi M, Baldassarre D, Amato M, et al. Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-IMilano mutant. Circulation 2007; 116: 2165-72.
14. Milano carriers and transgenic mice. Arterioscler Thromb Vasc Biol 1999; 19: 1257-62.
15. Milano Dimer Effectively Promotes ATP-binding Cassette A1-mediated Cell Cholesterol Efflux. J Biol Chem 2007; 282: 5125-32.
16. Shah PK, Yano J, Reyes O, et al. High-dose recombinant apolipoprotein A-IMilano mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization. Circulation 2001; 103: 3047-50.
17. Milano infusion into rabbit carotid artery rapidly removes lipid from fatty streaks. Circ Res 2002; 90: 974-80.
18. Parolini C, Marchesi M, Lorenzon P, et al. Dose-related effects of repeated ETC.-216 (recombinant apolipoprotein A-IMilano/1-palmitoyl-2-oleoyl phosphatidylcholine complexes) administrations on rabbit lipid-rich soft plaques: in vivo assessment by intravascular ultrasound and magnetic resonance imaging. J Am Coll Cardiol 2008; 51: 1098-103.
19. Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 2003; 290: 2292-300.
20. Parolini C, Chiesa G, Zhu Y, et al. Targeted replacement of mouse apolipoprotein A-I with human ApoA-I or the mutant ApoA-IMilano. Evidence of ApoA-IM impaired hepatic secretion. J Biol Chem 2003; 278: 4740-46.
21. Mardones P, Quinones V, Amigo L, et al. Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice. J Lipid Res 2001; 42: 170-80.
22. Roda A, Gioacchini AM, Cerre C, Baraldini M. High-performance liquid chromatographic-electrospray mass spectrometric analysis of bile acids in biological fluids. J Chromatogr B Biomed Appl 1995; 665: 281-94.
23. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226: 497-509.
24. De Fabiani E, Caruso D, Cavaleri M, Galli Kienle M, Galli G. Cholesta-5, 7, 9(11)-trien-3 beta-ol found in plasma of patients with Smith-Lemli-Opitz syndrome indicates formation of sterol hydroperoxide. J Lipid Res 1996; 37: 2280-87.
25. Yu C, Wang F, Kan M, et al. Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. J Biol Chem 2000; 275: 15482-89.
26. Jung D, Inagaki T, Gerard RD, et al. FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption. J Lipid Res 2007; 48: 2693-700.
27. Milano dimer. Biochemistry 1999; 38: 16307-14.
28. Milano: evaluation of the antiatherogenic effects in knock-in mouse model. Atherosclerosis 2005; 183: 222-9.
29. Groen AK, Bloks VW, Bandsma RH, et al. Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL. J Clin Invest 2001; 108: 843-50.
30. Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I. Nature 1991; 353: 265-7.
31. Purcell-Huynh DA, Farese RV Jr, Johnson DF, et al. Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet. J Clin Invest 1995; 95: 2246-57.
32. Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 2003; 83: 633-71.
33. Lee FY, Lee H, Hubbert ML, Edwards PA, Zhang Y. FXR, a multipurpose nuclear receptor. Trends Biochem Sci 2006; 31: 572-80.
34. Calkin AC, Tontonoz P. Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat Rev Mol Cell Biol 2012; 13: 213-24.
35. Peet DJ, Turley SD, Ma W, et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 1998; 93: 693-704.
36. Spady DK. Reverse cholesterol transport and atherosclerosis regression. Circulation 1999; 100: 576-8.
37. Wellington CL, Walker EK, Suarez A, et al. ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation. Lab Invest 2002; 82: 273-83.
38. Arakawa R, Yokoyama S. Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation. J Biol Chem 2002; 277: 22426-9.
39. Singaraja RR, Bocher V, James ER, et al. Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1. J Biol Chem 2001; 276: 33969-79.